27429532|t|Autoimmune Myelofibrosis in Systemic Lupus Erythematosus Report of Two Cases and Review of the Literature
27429532|a|Autoimmune myelofibrosis (AIMF) is a rare entity of steroid - responsive bone marrow fibrosis that accompanies a variety of autoimmune diseases, particularly systemic lupus erythematosus (SLE). Rarely it may occur in patients with autoimmune markers but no definable autoimmune disease (Primary-AIMF). We report the cases of two young women with SLE - associated AIMF (SLE - AIMF). The first patient was a young woman who had pancytopenia, massive splenomegaly and reticulin fibrosis in the marrow biopsy. The pancytopenia and splenomegaly resolved completely within weeks of treatment with corticosteroids. Repeat marrow biopsy showed marked regression of marrow fibrosis. The second patient was a young woman with fever, anasarca, bicytopenia and reticulin fibrosis in the marrow biopsy. Steroid therapy resulted in rapid clinical improvement and resolution of pancytopenia. A review of the literature revealed a total of 30 patients with SLE - AIMF reported to- date. Patients with SLE - AIMF are young women with SLE and blood cytopenia who are found to have increased bone marrow reticulin on marrow biopsy. Steroid therapy results in rapid hematological recovery and regression of marrow fibrosis. Whether AIMF is one of several hematological complications of SLE, or represents a unique and distinct subset of patients with SLE in not clear. Prospective studies with longer follow-up are needed to better define the prevalence and clinical spectrum of SLE - AIMF.
27429532	0	24	Autoimmune Myelofibrosis	T038	UMLS:C0026987
27429532	28	56	Systemic Lupus Erythematosus	T038	UMLS:C0024141
27429532	95	105	Literature	T170	UMLS:C0023866
27429532	106	130	Autoimmune myelofibrosis	T038	UMLS:C0026987
27429532	132	136	AIMF	T038	UMLS:C0026987
27429532	158	165	steroid	T103	UMLS:C0038317
27429532	179	199	bone marrow fibrosis	T038	UMLS:C0026987
27429532	230	249	autoimmune diseases	T038	UMLS:C0004364
27429532	264	292	systemic lupus erythematosus	T038	UMLS:C0024141
27429532	294	297	SLE	T038	UMLS:C0024141
27429532	337	355	autoimmune markers	T201	UMLS:C0005516
27429532	373	391	autoimmune disease	T038	UMLS:C0004364
27429532	393	405	Primary-AIMF	T038	UMLS:C0001815
27429532	441	446	women	T098	UMLS:C0043210
27429532	452	455	SLE	T038	UMLS:C0024141
27429532	469	473	AIMF	T038	UMLS:C0026987
27429532	475	478	SLE	T038	UMLS:C0024141
27429532	481	485	AIMF	T038	UMLS:C0026987
27429532	518	523	woman	T098	UMLS:C0043210
27429532	532	544	pancytopenia	T038	UMLS:C0030312
27429532	571	589	reticulin fibrosis	T033	UMLS:C1335762
27429532	597	610	marrow biopsy	T058	UMLS:C0005954
27429532	616	628	pancytopenia	T038	UMLS:C0030312
27429532	633	645	splenomegaly	T033	UMLS:C0038002
27429532	646	654	resolved	T033	UMLS:C3714811
27429532	697	712	corticosteroids	T103	UMLS:C3536709
27429532	721	734	marrow biopsy	T058	UMLS:C0005954
27429532	742	759	marked regression	T038	UMLS:C0684320
27429532	763	778	marrow fibrosis	T038	UMLS:C0026987
27429532	811	816	woman	T098	UMLS:C0043210
27429532	822	827	fever	T033	UMLS:C0015967
27429532	829	837	anasarca	T033	UMLS:C0013604
27429532	839	850	bicytopenia	T033	UMLS:C1142446
27429532	855	873	reticulin fibrosis	T033	UMLS:C1335762
27429532	881	894	marrow biopsy	T058	UMLS:C0005954
27429532	896	911	Steroid therapy	T058	UMLS:C0149783
27429532	969	981	pancytopenia	T038	UMLS:C0030312
27429532	999	1009	literature	T170	UMLS:C0023866
27429532	1047	1050	SLE	T038	UMLS:C0024141
27429532	1053	1057	AIMF	T038	UMLS:C0026987
27429532	1091	1094	SLE	T038	UMLS:C0024141
27429532	1097	1101	AIMF	T038	UMLS:C0026987
27429532	1112	1117	women	T098	UMLS:C0043210
27429532	1123	1126	SLE	T038	UMLS:C0024141
27429532	1131	1146	blood cytopenia	T038	UMLS:C0010828
27429532	1179	1200	bone marrow reticulin	T033	UMLS:C1335762
27429532	1204	1217	marrow biopsy	T058	UMLS:C0005954
27429532	1219	1234	Steroid therapy	T058	UMLS:C0149783
27429532	1279	1289	regression	T038	UMLS:C0684320
27429532	1293	1308	marrow fibrosis	T038	UMLS:C0026987
27429532	1318	1322	AIMF	T038	UMLS:C0026987
27429532	1355	1368	complications	T038	UMLS:C0009566
27429532	1372	1375	SLE	T038	UMLS:C0024141
27429532	1437	1440	SLE	T038	UMLS:C0024141
27429532	1455	1474	Prospective studies	T062	UMLS:C0033522
27429532	1487	1496	follow-up	T058	UMLS:C1522577
27429532	1565	1568	SLE	T038	UMLS:C0024141
27429532	1571	1575	AIMF	T038	UMLS:C0026987